MeSH term
Frequency | Condition_Probility | Female | 36 | 0.0 |
Humans | 97 | 0.0 |
Pregnancy | 2 | 0.0 |
Animals | 22 | 0.0 |
Cell Count | 2 | 0.0 |
Cell Differentiation/physiology | 2 | 0.0 |
Proteins/genetics/*metabolism | 4 | 0.0 |
Rats | 7 | 0.0 |
Recombinant Proteins/pharmacology | 3 | 0.0 |
Research Support, Non-U.S. Gov't | 76 | 0.0 |
Stomach Neoplasms | 2 | 6.0 |
Transfection | 4 | 0.0 |
Oligonucleotide Array Sequence Analysis | 3 | 0.0 |
Dimerization | 6 | 0.0 |
Dose-Response Relationship, Drug | 4 | 0.0 |
Models, Biological | 2 | 0.0 |
Protein Biosynthesis | 6 | 0.0 |
Receptors, Estrogen/analysis | 2 | 0.0 |
Tumor Cells, Cultured | 14 | 0.0 |
Adult | 18 | 0.0 |
Aged | 19 | 0.0 |
Biliary Tract Diseases/metabolism/*pathology | 2 | 100.0 |
Growth Substances/*biosynthesis | 2 | 4.0 |
Immunohistochemistry | 22 | 0.0 |
Male | 29 | 0.0 |
Middle Aged | 28 | 0.0 |
*Mucins | 27 | 39.0 |
*Muscle Proteins | 43 | 14.0 |
*Neuropeptides | 38 | 30.0 |
Peptides | 3 | 4.0 |
Aged, 80 and over | 9 | 0.0 |
Prognosis | 4 | 0.0 |
In Situ Hybridization | 4 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 17 | 0.0 |
Comparative Study | 11 | 0.0 |
English Abstract | 2 | 0.0 |
Goblet Cells/metabolism | 2 | 40.0 |
Blotting, Western | 10 | 0.0 |
Oxytocin/*analysis | 2 | 20.0 |
Proteins/*analysis | 4 | 2.0 |
Swine | 3 | 0.0 |
Ki-67 Antigen/metabolism | 2 | 0.0 |
Proteins/*metabolism | 16 | 1.0 |
Receptors, Estrogen/metabolism | 2 | 0.0 |
Regression Analysis | 2 | 0.0 |
Cell Differentiation | 3 | 0.0 |
Growth Substances/*metabolism | 6 | 4.0 |
Peptides/*metabolism | 16 | 8.0 |
Phenotype | 3 | 0.0 |
Biopsy | 2 | 0.0 |
Case-Control Studies | 4 | 0.0 |
Chronic Disease | 4 | 0.0 |
RNA, Messenger/analysis | 5 | 0.0 |
Gastric Mucosa/*metabolism | 2 | 6.0 |
Time Factors | 4 | 0.0 |
Base Sequence | 8 | 0.0 |
Cell Division | 2 | 0.0 |
Cell Line, Tumor | 5 | 0.0 |
DNA Primers | 5 | 0.0 |
Kinetics | 3 | 0.0 |
Mucins/*physiology | 2 | 15.0 |
Adenocarcinoma/metabolism/*pathology | 2 | 3.0 |
Gene Expression/physiology | 2 | 0.0 |
Growth Substances/*genetics/metabolism | 5 | 22.0 |
Peptides/*genetics/metabolism | 4 | 14.0 |
Rabbits | 2 | 0.0 |
Rats, Wistar | 2 | 0.0 |
Stomach Neoplasms/metabolism/*pathology | 2 | 6.0 |
Gene Expression | 3 | 0.0 |
Genes, Structural/*genetics | 2 | 0.0 |
Growth Substances/*genetics | 6 | 5.0 |
Mice | 9 | 0.0 |
Molecular Sequence Data | 13 | 0.0 |
Peptides/*genetics | 7 | 7.0 |
Promoter Regions (Genetics) | 7 | 0.0 |
Sequence Alignment | 3 | 0.0 |
Sequence Analysis, DNA | 2 | 0.0 |
Sequence Homology, Nucleic Acid | 3 | 0.0 |
Tissue Distribution | 2 | 0.0 |
Amino Acid Sequence | 8 | 0.0 |
Cysteine/chemistry | 3 | 2.0 |
Disulfides/chemistry | 2 | 2.0 |
Models, Molecular | 4 | 0.0 |
Peptides/chemistry | 2 | 0.0 |
Protein Conformation | 2 | 0.0 |
Solutions | 2 | 1.0 |
Chromosome Mapping | 4 | 0.0 |
RNA, Messenger/genetics | 6 | 0.0 |
Sequence Homology, Amino Acid | 3 | 0.0 |
Mucins/*metabolism | 14 | 14.0 |
Muscle Proteins/*metabolism | 7 | 16.0 |
RNA, Messenger/metabolism | 10 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction/methods | 3 | 0.0 |
Up-Regulation | 3 | 0.0 |
*Helicobacter pylori | 2 | 1.0 |
Fluorescent Antibody Technique | 2 | 0.0 |
Mucins/metabolism | 2 | 4.0 |
Genes, Reporter | 4 | 0.0 |
*Promoter Regions (Genetics) | 2 | 0.0 |
Proteins/*genetics | 4 | 0.0 |
*Digestive Physiology | 2 | 6.0 |
Cytosol/metabolism | 2 | 0.0 |
Protein Binding | 2 | 0.0 |
Genes, Reporter/genetics | 2 | 0.0 |
RNA, Messenger/genetics/metabolism | 2 | 0.0 |
DNA Mutational Analysis | 2 | 0.0 |
Reference Values | 2 | 0.0 |
Stomach Neoplasms/*genetics/metabolism/pathology | 2 | 13.0 |
*Loss of Heterozygosity | 2 | 0.0 |
Proteins/*genetics/metabolism | 3 | 1.0 |
Gastric Mucosa/*chemistry | 2 | 15.0 |
Adolescent | 8 | 0.0 |
Child | 5 | 0.0 |
Neoplasm Proteins/*metabolism | 3 | 0.0 |
Stomach Neoplasms/*metabolism/pathology | 5 | 8.0 |
Binding Sites | 2 | 0.0 |
Transcription Factors/*metabolism | 3 | 0.0 |
Electrophoresis, Polyacrylamide Gel | 3 | 0.0 |
Mucus/chemistry | 2 | 50.0 |
Bronchitis/metabolism | 2 | 40.0 |
Fluorescent Antibody Technique, Indirect | 4 | 0.0 |
Immunoenzyme Techniques | 7 | 0.0 |
Peptides/metabolism | 4 | 1.0 |
Stomach/*metabolism | 2 | 11.0 |
Actins/biosynthesis | 2 | 4.0 |
Age Factors | 3 | 0.0 |
Breast Neoplasms/chemistry/*metabolism/*pathology | 2 | 100.0 |
Carcinoma, Ductal, Breast/chemistry/*metabolism/*pathology | 2 | 100.0 |
Lymphatic Metastasis | 2 | 0.0 |
Neoplasm Staging | 4 | 0.0 |
RNA, Messenger/isolation & purification/metabolism | 2 | 10.0 |
Receptors, Estrogen/*metabolism | 4 | 1.0 |
Receptors, Progesterone/*metabolism | 4 | 3.0 |
Tumor Markers, Biological/biosynthesis/*metabolism | 2 | 66.0 |
In Vitro | 3 | 0.0 |
Cell Division/drug effects | 5 | 0.0 |
*Protein Biosynthesis | 3 | 0.0 |
Proteins/genetics | 5 | 0.0 |
Proteins/*pharmacology | 2 | 2.0 |
Cell Transformation, Neoplastic | 3 | 0.0 |
Precancerous Conditions/*metabolism/pathology | 2 | 9.0 |
Blotting, Northern | 3 | 0.0 |
Growth Substances/genetics/*metabolism | 2 | 4.0 |
Mice, Transgenic | 3 | 0.0 |
Polymerase Chain Reaction | 2 | 0.0 |
Cell Line | 2 | 0.0 |
Cell Movement/drug effects | 2 | 0.0 |
CA-15-3 Antigen/genetics | 2 | 14.0 |
Gene Expression Regulation, Neoplastic | 3 | 0.0 |
Epithelial Cells/metabolism/pathology | 2 | 4.0 |
HT29 Cells | 4 | 2.0 |
Rats, Sprague-Dawley | 2 | 0.0 |
Tumor Markers, Biological/*metabolism | 2 | 0.0 |
Disulfides/*chemistry | 2 | 5.0 |
Enzyme-Linked Immunosorbent Assay | 3 | 0.0 |
Down-Regulation | 2 | 0.0 |
RNA, Neoplasm/genetics | 4 | 1.0 |
*Proteins | 12 | 2.0 |
Structure-Activity Relationship | 2 | 0.0 |
Sensitivity and Specificity | 2 | 0.0 |
Child, Preschool | 4 | 0.0 |
Luciferases/genetics | 2 | 0.0 |
Promoter Regions (Genetics)/*genetics | 2 | 0.0 |
Estradiol/*analogs & derivatives/pharmacology | 2 | 4.0 |
Tamoxifen/*analogs & derivatives/pharmacology | 2 | 8.0 |
Retrospective Studies | 2 | 0.0 |
Estrogen Receptor alpha | 2 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 3 | 0.0 |
Mucins/genetics | 2 | 10.0 |
Peptides/genetics | 4 | 4.0 |
Binding Sites/genetics | 2 | 0.0 |
*Mutation | 2 | 0.0 |
Peptides/*analysis | 3 | 4.0 |
Research Support, U.S. Gov't, P.H.S. | 2 | 0.0 |
Transcription, Genetic | 2 | 0.0 |
Peptides/genetics/*metabolism | 2 | 6.0 |
Epithelial Cells/metabolism | 2 | 0.0 |
*Gene Expression Regulation | 2 | 0.0 |
Growth Substances/*biosynthesis/genetics | 2 | 7.0 |
Polymerase Chain Reaction/methods | 2 | 0.0 |
